stella
beta
Tislelizumab and Metronomic Capecitabine as Maintenance in High-risk Locoregionally-advanced Nasopharyngeal Carcinoma — Stella
Recruiting
Back to Nasopharyngeal Carcinoma trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(2 sites)
Singapore
National Cancer Centre Singapore, Singapore
Tan Tock Seng Hospital, Singapore
View full record on ClinicalTrials.gov